G-Protein Coupled Receptors Market by Product (Cell Culture Reagents, Cell Lines, Detection Kits), Assay Type (Calcium Functional Assays, cAMP Functional Assays, Internalization Assays), Application - Global Forecast 2024-2030

G-Protein Coupled Receptors Market by Product (Cell Culture Reagents, Cell Lines, Detection Kits), Assay Type (Calcium Functional Assays, cAMP Functional Assays, Internalization Assays), Application - Global Forecast 2024-2030


The G-Protein Coupled Receptors Market size was estimated at USD 3.31 billion in 2023 and expected to reach USD 3.51 billion in 2024, at a CAGR 6.27% to reach USD 5.07 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the G-Protein Coupled Receptors Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the G-Protein Coupled Receptors Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the G-Protein Coupled Receptors Market, highlighting leading vendors and their innovative profiles. These include Abalone Bio, Inc., Abcam PLC, Addex Therapeutics, Becton, Dickinson and Company, BioInvenu,Inc., Cisbio Bioassays SAS, Confo Therapeutics, Corning Incorporated, Crinetics Pharmaceuticals, Inc., Domain Therapeutics SA, Enzo Life Sciences, Inc., Escient Pharmaceuticals, Eurofins Scientific SE, Merck KGaA, Molecular Devices, LLC, OKYO Pharma, Limited, Orion Biotechnology, OSE Immunotherapeutics, PerkinElmer Inc., Promega Corporation, QIAGEN GmbH, Septerna, Sosei Group Corporation, Tectonic Therapeutic, Teon Therapeutics, Inc., Thermo Fisher Scientific Inc., and WuXi AppTec.

Market Segmentation & Coverage



This research report categorizes the G-Protein Coupled Receptors Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Cell Culture Reagents
Cell Lines
Detection Kits
Ligands
Assay Type
Calcium Functional Assays
cAMP Functional Assays
Internalization Assays
Radioligand Binding and GTPγS Functional Assays
Trafficking Assays
β-Arrestin Functional Assays
Application
Cancer Research
Cardiovascular Research
CNS Research
Inflammation Research
Metabolic Research
Respiratory Research
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the G-Protein Coupled Receptors Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the G-Protein Coupled Receptors Market?
3. What are the technology trends and regulatory frameworks in the G-Protein Coupled Receptors Market?
4. What is the market share of the leading vendors in the G-Protein Coupled Receptors Market?
5. Which modes and strategic moves are suitable for entering the G-Protein Coupled Receptors Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. G-Protein Coupled Receptors Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising number of cardiovascular diseases across the globe
5.1.1.2. Increasing expenditure for the development of novel pharmaceutical drugs and therapies
5.1.1.3. Ongoing research activities to reduce the cancer burden
5.1.2. Restraints
5.1.2.1. Associated high cost with G-protein coupled receptors (GPCRs)
5.1.3. Opportunities
5.1.3.1. Surge in the number of regulatory approvals for novel drugs and therapies
5.1.3.2. Emerging advances in the molecular understanding of G protein-coupled receptors
5.1.4. Challenges
5.1.4.1. Lack of skilled professionals or trained subject expertise coupled with stringent approval norms
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. G-Protein Coupled Receptors Market, by Product
6.1. Introduction
6.2. Cell Culture Reagents
6.3. Cell Lines
6.4. Detection Kits
6.5. Ligands
7. G-Protein Coupled Receptors Market, by Assay Type
7.1. Introduction
7.2. Calcium Functional Assays
7.3. cAMP Functional Assays
7.4. Internalization Assays
7.5. Radioligand Binding and GTPγS Functional Assays
7.6. Trafficking Assays
7.7. β-Arrestin Functional Assays
8. G-Protein Coupled Receptors Market, by Application
8.1. Introduction
8.2. Cancer Research
8.3. Cardiovascular Research
8.4. CNS Research
8.5. Inflammation Research
8.6. Metabolic Research
8.7. Respiratory Research
9. Americas G-Protein Coupled Receptors Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific G-Protein Coupled Receptors Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa G-Protein Coupled Receptors Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Abalone Bio, Inc.
13.1.2. Abcam PLC
13.1.3. Addex Therapeutics
13.1.4. Becton, Dickinson and Company
13.1.5. BioInvenu,Inc.
13.1.6. Cisbio Bioassays SAS
13.1.7. Confo Therapeutics
13.1.8. Corning Incorporated
13.1.9. Crinetics Pharmaceuticals, Inc.
13.1.10. Domain Therapeutics SA
13.1.11. Enzo Life Sciences, Inc.
13.1.12. Escient Pharmaceuticals
13.1.13. Eurofins Scientific SE
13.1.14. Merck KGaA
13.1.15. Molecular Devices, LLC
13.1.16. OKYO Pharma, Limited
13.1.17. Orion Biotechnology
13.1.18. OSE Immunotherapeutics
13.1.19. PerkinElmer Inc.
13.1.20. Promega Corporation
13.1.21. QIAGEN GmbH
13.1.22. Septerna
13.1.23. Sosei Group Corporation
13.1.24. Tectonic Therapeutic
13.1.25. Teon Therapeutics, Inc.
13.1.26. Thermo Fisher Scientific Inc.
13.1.27. WuXi AppTec
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. G-PROTEIN COUPLED RECEPTORS MARKET RESEARCH PROCESS
FIGURE 2. G-PROTEIN COUPLED RECEPTORS MARKET SIZE, 2023 VS 2030
FIGURE 3. G-PROTEIN COUPLED RECEPTORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. G-PROTEIN COUPLED RECEPTORS MARKET DYNAMICS
FIGURE 7. G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2023 VS 2030 (%)
FIGURE 10. G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. G-PROTEIN COUPLED RECEPTORS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. G-PROTEIN COUPLED RECEPTORS MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings